Assoc. Prof. AHMET ÇAĞKAN İNKAYA

Publication Network

Articles 152

1. Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment-naïve individuals with HIV-1 in Türkiye

Ozdemir A., Demir T., Polat C., Uzun M., Sönmezer M. Ç., Ergunay K., et al.

HIV MEDICINE , vol.26, no.11, pp.1739-1747, 2025 (SCI-Expanded, Scopus) Sustainable Development

2. Markers of NETosis in Acute Brucellosis

gürsoy g., Canpinar H., Inkaya A. C.

Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi , vol.30, no.2, pp.156-164, 2025 (ESCI)

3. Molecular epidemiology of JC polyomavirus genotypes in PLWH from Turkey

AYDOĞAN O., Saylan E. G., METE B., İNKAYA A. Ç., GÜVEN Ö.

JOURNAL OF NEUROVIROLOGY , 2025 (SCI-Expanded)

4. Management of Infections Caused by Stenotrophomonas maltophilia: A Traditional Review

Gul Yumrucu F., KARA E., TELLİ DİZMAN G., İNKAYA A. Ç., DEMİRKAN S. K., METAN G.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.30, no.1, pp.1-10, 2025 (ESCI)

5. A Case of Axillary Arterial Aneurysm Due to Group D Non- Typhoidal Salmonella

Kaygusuz B., GİRGİN S., İNKAYA A. Ç., ALTUN B.

TURKISH JOURNAL OF NEPHROLOGY , vol.34, no.1, pp.63-64, 2025 (ESCI)

6. Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study

Metan G., Ciftcioglu A., Saba R., Kilic A. U., ÖZDEMİR K., ÇAĞ Y., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , no.1, pp.75-88, 2025 (SCI-Expanded) Sustainable Development

7. Advances in Virus-Specific T-Cell Therapy for Polyomavirus Infections: A Comprehensive Review

Alkan B., Tuncer M. A., İNKAYA A. Ç.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.64, no.5, 2024 (SCI-Expanded)

8. Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosis

BAKIR EKİNCİ P., BAYRAKTAR ALKAN İ., ER A. G., Pinar A., İNKAYA A. Ç., DEMİRKAN S. K., et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , no.10, 2024 (SCI-Expanded)

9. Drug Burden and Deprescribing in People Living with HIV

TURHAN F. N. B., KARA E., İNKAYA A. Ç., DEMİRKAN K., ÜNAL S.

Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi , vol.29, no.3, pp.313-324, 2024 (ESCI)

10. Mpox: what sexual health physicians need to know?

İNKAYA A. Ç.

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH , vol.36, no.6, pp.556-561, 2024 (SCI-Expanded)

11. Inhaled Aviptadil is a new hope for recovery of lung damage due to COVID-19

Esendagli D. R., Sari N., AKHAN S., ARSLAN S., Yilmaz G., AKSOY F., et al.

EUROPEAN RESPIRATORY JOURNAL , 2024 (SCI-Expanded)

12. Psychiatrists’ and Infectious Disease Physicians’ Awareness and Knowledge Level of Drug-Drug Interactions Between Antiretrovirals and Psychotropics: A Comparative Questionnaire-Based Study

YALÇIN N., İNKAYA A. Ç., KARA E., BAŞAR K., KARADAĞ Ö., DEMİRKAN S. K., et al.

FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , vol.49, no.2, pp.333-344, 2024 (Scopus)

13. Compliance with guideline recommendations in the management of patients with hospitalized community-acquired pneumonia

BAKIR EKİNCİ P., KARA E., TELLİ DİZMAN G., Metin S., İNKAYA A. Ç., Demirkan K., et al.

Journal of Investigative Medicine , vol.72, no.4, pp.349-358, 2024 (SCI-Expanded, Scopus)

14. Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study

FIRAT O., KARA E., MALKAN Ü. Y., Demirkan K., İNKAYA A. Ç.

Thrombosis Research , vol.236, pp.155-160, 2024 (SCI-Expanded)

15. Treatment of Pneumocystis jirovecii Pneumonia with Caspofungin and Clindamycin: An HIV Patient and Literature Review

YILMAZ G., KAYA O., İNKAYA A. Ç., ÜNAL O., Temel E. N., AKÇAM F. Z., et al.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.29, no.1, pp.139-144, 2024 (ESCI)

16. Evaluation of infectious diseases physicians' attitudes to dyslipidemia management in PLWH

BALLI TURHAN F. N., KARA E., UYAROĞLU O. A., ÇALIK BAŞARAN N., DEMİRKAN S. K., ÜNAL S., et al.

POSTGRADUATE MEDICINE , vol.136, pp.720-725, 2024 (SCI-Expanded)

17. Comparison of clinician preference and HIV-ASSIST recommendations in antiretroviral therapy decision-making: A single center experience from Turkiye

Akbulut I., Odemis I., Atalay S., İNKAYA A. Ç.

International Journal of STD and AIDS , 2024 (SCI-Expanded)

18. A Case of Relapsing Hyponatremia Associated with Fungal Sinusitis

APAYDIN ROLLAS A. E., ÖNAL C., ÖZBERK U., İNKAYA A. Ç., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., et al.

CASE REPORTS IN NEPHROLOGY AND DIALYSIS , no.1, pp.178-184, 2024 (ESCI)

19. Effect on the HIV diagnosis rates of Integration of AIDS defining and indicator conditions into the hospital information system: HIV-IC study

Unal S., Koc M. M., Aydogmus F. K., Bayindir Y., GENÇER S., Tasova Y., et al.

HIV MEDICINE , pp.319-320, 2023 (SCI-Expanded)

20. Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination

Tavukcuoglu E., Yanik H., Parveen M., Uluturk S., DURUSU TANRIÖVER M., İNKAYA A. Ç., et al.

Scientific Reports , vol.13, no.1, 2023 (SCI-Expanded, Scopus)

21. Initial Empirical Antibiotic Treatment in Covid-19 Patients is Related with Excess Adverse Drug Reactions Without Clinical Benefit

BAKIR EKİNCİ P., KARA E., TELLİ DİZMAN G., SÖNMEZER M. Ç., İNKAYA A. Ç., DEMİRKAN S. K., et al.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.0, 2023 (ESCI)

22. Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe

Gokengin D., Noori T., Alemany A., Bienkowski C., Liegon G., Carrillo J., et al.

LANCET REGIONAL HEALTH-EUROPE , vol.34, 2023 (SCI-Expanded) Sustainable Development

23. Investigation of the Frequency of Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and Mycoplasma genitalium in Men Living with HIV in Terms of Sociodemographic Characteristics and Behavioral Risk Factors HIV ile Yaşayan Erkeklerde Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis ve Mycoplasma genitalium Sıklığının Sosyodemografik Özellikler ve Davranışsal Risk Faktörleri ile Birlikte Araştırılması

AYAZ CEYLAN Ç. M., Karakaplan N. D., İNKAYA A. Ç., ÇAKIR B., ÜNAL S., Zarakolu P.

Mikrobiyoloji bulteni , vol.57, no.3, pp.378-389, 2023 (SCI-Expanded)

24. Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?

Duran E., Kilic L., Durhan G., Inkaya A. Ç., Guven G. S., Karakaya G., et al.

Annals of the rheumatic diseases , vol.82, no.4, 2023 (SCI-Expanded)

25. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

Pérez-Galera S., Bravo-Ferrer J. M., Paniagua M., Kostyanev T., de Kraker M. E., Feifel J., et al.

eClinicalMedicine , vol.57, 2023 (SCI-Expanded)

26. Impact of pharmacist-led educational intervention on pneumococcal vaccination rates in cancer patients: a randomized controlled study

ÖZDEMİR N., AKTAŞ B. E., Gulmez A., İNKAYA A. Ç., Bayraktar-Ekincioglu A., Kilickap S., et al.

Supportive Care in Cancer , vol.31, no.3, 2023 (SCI-Expanded)

27. Prevalence of Common Human Coronaviruses (NL63, 229E, and OC43) in Adults before the COVID-19 Pandemic: a Single-Center Study from Turkey, 2015-2020.

Sonmezer M. C., Sahin T. K., Erul E., Dizman G., Inkaya A. Ç., Alp A., et al.

Japanese journal of infectious diseases , vol.76, no.1, pp.27-33, 2023 (SCI-Expanded, Scopus)

28. Nitroimidazole Derivative Antimicrobial Drugs and Liver Injury

Balaban U., İnkaya A. Ç., Kara E.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.28, no.3, pp.313-320, 2023 (ESCI)

29. Detection of Non-Alcoholic Fatty Liver Disease with Non-invasive Tools in Turkish People Living with HIV and with Apparently Normal Liver Function

Başaran N. Ç., İdilman İ., Tokuçoğlu H. A., ONUR M. R., SÖNMEZER M. Ç., ÖZIŞIK L., et al.

Current HIV research , vol.21, no.3, pp.192-201, 2023 (SCI-Expanded)

30. A retrospective study: Can dual ART mitigate the risk of potential drug-drug interactions among PLWH under stable ART?

İNKAYA A. Ç., BALLI F. N., KARA E., Demirkan K., ÜNAL S.

Turkish Journal of Medical Sciences , vol.53, no.5, pp.1505-1511, 2023 (SCI-Expanded)

31. Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19 Patients in the Intensive Care Unit: A Case-Control Study

Canbaz H., İdiz U. O., Cankar Dal H., Kaçıroğlu F., Taş S., Çubukçu H. C., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.39, no.4, pp.222-229, 2022 (SCI-Expanded)

32. Frailty and sarcopenia among Turkish people aged 40 and above living with HIV

Houssein M., İNKAYA A. Ç., BALCI C., EŞME M., SÖNMEZER M. Ç., ÜNAL S., et al.

HIV MEDICINE , vol.23, no.10, pp.1061-1068, 2022 (SCI-Expanded) Sustainable Development

33. An Unusual Case of Early Dental Implant Failure in an Otherwise-Healthy Patient due to Actinomycosis

PARLAK H. M., AKMAN A. C., Comerdov E., KÖSEMEHMETOĞLU K., İNKAYA A. Ç., KEÇELİ H. G.

JOURNAL OF ORAL IMPLANTOLOGY , vol.48, no.3, pp.226-236, 2022 (SCI-Expanded)

34. Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum antibiotics require approval of an infectious diseases physician?

Metan G., UZUN Ö., Dizman G., SÖNMEZER M. Ç., İNKAYA A. Ç., HAZIROLAN G., et al.

Infection control and hospital epidemiology , vol.43, no.6, pp.802-804, 2022 (SCI-Expanded, Scopus)

35. Carbapenem-resistant Klebsiella pneumoniae meningitis and abscess treated with ceftazidime-avibactam

PEKTEZEL M. Y., Isikay I., GÖÇMEN R., İNKAYA A. Ç.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA , vol.40, no.6, pp.332-333, 2022 (SCI-Expanded)

36. Adenosine Deaminase Type II Deficiency: Severe Chronic Neutropenia, Lymphoid Infiltration in Bone Marrow, and Inflammatory Features.

SÜLEYMAN M., TAN Ç., ÜNER A., Inkaya C., Aytac Ş. S., BÜYÜKAŞIK Y., et al.

Immunological investigations , vol.51, no.3, pp.558-566, 2022 (SCI-Expanded, Scopus)

37. A Multidisciplinary Approach to Opportunistic Infections in a Late-presenter Person Living with HIV

Bahar A. R., Bahar Y., UYSAL S., SÖNMEZER M. Ç., GÜLMEZ KIVANÇ D., ÖNDER S. Ç., et al.

Mediterranean Journal of Infection, Microbes and Antimicrobials , vol.11, no.1, 2022 (Peer-Reviewed Journal)

38. Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels

Bakir Ekinci P., KARA E., ER A. G., İNKAYA A. Ç., Demirkan K., UZUN Ö.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , vol.88, no.3, pp.1387-1391, 2022 (SCI-Expanded) Sustainable Development

39. A COVID-19 first evaluation clinic at a university hospital in Turkey.

Telli Dizman G., Metan G., Ayaz Ceylan Ç. M., Altunay H., Uzun M., Gürsoy G., et al.

Turkish journal of medical sciences , vol.52, no.1, pp.1-10, 2022 (SCI-Expanded, Scopus, TRDizin)

40. Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in Turkey

SÖNMEZER M. Ç., Erul E., ŞAHİN T. K., Rudvan Al I., Cosgun Y., Korukluoglu G., et al.

VACCINES , vol.10, no.2, 2022 (SCI-Expanded, Scopus)

41. Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years

Sahin E. A., Mavi D., KARA E., SÖNMEZER M. Ç., İNKAYA A. Ç., ÜNAL S.

POSTGRADUATE MEDICINE , vol.134, no.6, pp.635-640, 2022 (SCI-Expanded)

42. Behçet's Disease-related Budd–Chiari Syndrome Successfully Managed with anti-TNF Antibody: A Case Report and Review of the Literature

ERUL E., Uzun G. S., KÖKSAL D., KESKİN O., UYSAL S., İNKAYA A. Ç., et al.

European Journal of Case Reports in Internal Medicine , vol.9, no.8, 2022 (Scopus)

43. Disseminated Brucella melitensis infection following canakinumab treatment.

Oral H., Sönmezer M. Ç., Yıldız A. E., Hazırolan G., Metan G., İnkaya A. Ç.

Travel medicine and infectious disease , vol.45, pp.102227, 2022 (SCI-Expanded)

44. Evaluation of the peripheral blood T and B cell subsets and IRF-7 variants in adult patients with severe influenza virus infection

Basaran N. C., TAN Ç., ÖZIŞIK L., ÖZBEK B., İNKAYA A. Ç., ÖZYAVUZ ALP Ş., et al.

HEALTH SCIENCE REPORTS , vol.5, no.1, 2022 (ESCI, Scopus)

45. Comprehensive Assessment of Common Medical Problems in Adult Patients with Hemophilia A: A Single-Center Experience in Turkey

Aydin M. S., Ciftciler R., İNKAYA A. Ç., AKSU S.

GAZI MEDICAL JOURNAL , vol.33, no.1, pp.1-4, 2022 (ESCI)

46. COVID-19, parvovirus and acute HIV infection in the gamut of diagnosis of fever and rash

UYAROĞLU O. A., ÖZIŞIK L., ÇALIK BAŞARAN N., Telli Dizman G., Tas Z., ÖZDEDE M., et al.

MARMARA MEDICAL JOURNAL , vol.35, no.1, pp.115-120, 2022 (ESCI)

47. Evaluation of Corrected QT Intervals of 74 COVID19 Patients Treated with Hydroxychloroquine in Combination with or without Azithromycin and/or Favipiravir

UYAROĞLU O. A., ŞENER Y. Z., ÖZDEDE M., ÇALIK BAŞARAN N., ÖZIŞIK L., ŞAHİN T. K., et al.

European Journal of Therapeutics , vol.27, no.4, pp.311-317, 2021 (ESCI) Sustainable Development

48. AI-Based Quantitative CT Analysis of Temporal Changes According to Disease Severity in COVID-19 Pneumonia

ARDALI DÜZGÜN S., DURHAN G., DEMİRKAZIK F., IRMAK İ., KARAKAYA KARABULUT J., AKPINAR E., et al.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY , vol.45, no.6, pp.970-978, 2021 (SCI-Expanded) Sustainable Development

49. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder

Sarohan A. R., KIZIL M., İNKAYA A. Ç., Mahmud S., Akram M., Cen O.

CELLULAR SIGNALLING , vol.87, 2021 (SCI-Expanded) Sustainable Development

50. Tsukamurella paurometabola peritonitis in a patient on automated peritoneal dialysis

Ismayilov R., Duran Z. C., HAZIROLAN G., İNKAYA A. Ç.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA , vol.39, no.8, pp.422, 2021 (SCI-Expanded)

51. Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19.

Aladag E., Tas Z., Ozdemir B. S., Akbaba T. H., Akpınar M. G., Goker H., et al.

Journal of the renin-angiotensin-aldosterone system : JRAAS , vol.2021, pp.5509280, 2021 (SCI-Expanded)

52. A case report of tigecycline induced acute pancreatitis in a renal transplant patient and review of the literature: Should we avoid tigecycline in patients on calcineurin inhibitors?

YAZIRLI B., KARA E., İNKAYA A. Ç., MADEN S., ÖZBERK U., YILDIRIM T., et al.

TRANSPLANT INFECTIOUS DISEASE , vol.23, no.4, 2021 (SCI-Expanded) Sustainable Development

53. Functional responsiveness of memory T cells from COVID-19 patients

Tavukcuoglu E., Horzum U., İNKAYA A. Ç., ÜNAL S., ESENDAĞLI G.

CELLULAR IMMUNOLOGY , vol.365, 2021 (SCI-Expanded) Sustainable Development

54. Should prolonged ceftriaxone infusions be preferred in septic patients?

Kara E., Bahap M., Inkaya A. Ç.

The American journal of emergency medicine , vol.44, pp.474-475, 2021 (SCI-Expanded)

55. First Confirmed Cases of 2019 Novel Coronavirus in a University Hospital in Turkey: Housemate Internists

UYAROĞLU O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., TAŞ Z., TELLİ DİZMAN G., İNKAYA A. Ç., et al.

Acta Medica , vol.52, no.1, pp.75-81, 2021 (TRDizin) Sustainable Development

56. Pharmacist intervention to improve patients' knowledge and attitude towards hepatitis B infection

Bahap M., Kara E., Sonmezer M. C., Inkaya A. Ç., Aydin-Hakli D., Unal S., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.4, 2021 (SCI-Expanded) Sustainable Development

57. COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey

Hagens A., İnkaya A. Ç., Yildirak K., Sancar M., van der Schans J., Acar Sancar A., et al.

VACCINES , vol.9, no.4, 2021 (SCI-Expanded, Scopus)

58. Cystoisospora belli infection in a renal transplant recipient: a case report and review of literature

ÖZMEN ÇAPIN B. B., GÜRSOY G., Tortop S., Jabrayilov J., İNKAYA A. Ç., ERGÜVEN S.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.15, no.4, pp.599-602, 2021 (SCI-Expanded)

59. Invasive aspergillosis due to Aspergillus section Usti: a multicenter retrospective study.

Glampedakis E., Cassaing S., Fekkar A., Dannaoui E., Bougnoux M., Bretagne S., et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , vol.72, pp.1379-1385, 2021 (SCI-Expanded)

60. Investigation of Intestinal Protozoon Prevalence in Immunocompromised Patients at a University Hospital

Kaya F., İnkaya A. Ç., Aksoy S., Abbasoğlu O., Ertenli A. İ., Büyükaşık Y., et al.

Turkiye parazitolojii dergisi , vol.45, pp.39-44, 2021 (Scopus)

61. COVID-19 at First Glance, Pulmonary Tuberculosis With a Glance in Depth

UYAROĞLU O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., İNKAYA A. Ç., Guven G. S.

JOURNAL OF EMERGENCY MEDICINE CASE REPORTS , vol.12, no.1, pp.22-24, 2021 (ESCI)

62. First confirmed cases of 2019 Novel Coronavirus in a university hospital in Turkey: housemate internists

Uyaroğlu O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., TAŞ Z., TELLİ DİZMAN G., İNKAYA A. Ç., et al.

Acta Medica , vol.52, no.1, pp.75-81, 2021 (TRDizin)

63. Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy.

İDİLMAN İ. S., Dizman G., Duzgun S. A., IRMAK İ., KARÇAALTINCABA M., İNKAYA A. Ç., et al.

European radiology , vol.31, pp.1090-1099, 2021 (SCI-Expanded, Scopus)

64. Persistent dermal lesions in a patient with previous history of visceral leishmaniasis

Jaiteh M. B., İNKAYA A. Ç., ÜNER A., ELÇİN G., ERGÜVEN S., KURTULAN O., et al.

PARASITOLOGY INTERNATIONAL , vol.80, 2021 (SCI-Expanded)

65. Favipiravir Use in COVID-19 Treatment

KARA E., İNKAYA A. Ç., Demirkan K., ÜNAL S.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.26, no.1, pp.1-11, 2021 (ESCI)

66. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients.

Karataş A., Malkan Ü. Y., Velet M., Demiroğlu H., Büyükaşik Y., Telli Dizman G., et al.

Turkish journal of medical sciences , vol.51, pp.1647-1652, 2021 (SCI-Expanded, Scopus, TRDizin)

67. Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study

UyaroĞlu O. A., BaŞaran N. Ç., ÖziŞik L., Dİzman G., EroĞlu İ., Şahİn T. K., et al.

INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE , vol.33, no.1, 2021 (SCI-Expanded, SSCI, Scopus)

68. Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients

İNKAYA A. Ç., KARA E., ÇALIK BAŞARAN N., ŞAHİN T. K., UYAROĞLU O. A., UZUN Ö., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.5, pp.2786-2788, 2021 (SCI-Expanded)

69. Clinical implications of fungal isolation from sputum in adult patients with cystic fibrosis

Irmak İ., ÇelebİoĞlu E., Karadenİz GÜven D., Huseynova X., İnkaya A. Ç., Er B., et al.

Turkish Journal of Medical Sciences , vol.51, no.3, pp.1191-1200, 2021 (SCI-Expanded)

70. Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis.

Çınar O., Sayınalp B., Aladağ K., Avşar K., Velet M., İnkaya A. Ç., et al.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , vol.59, pp.102821, 2020 (SCI-Expanded)

71. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

KARATAŞ A., İNKAYA A. Ç., DEMİROĞLU H., AKSU S., Haziyev T., ÇINAR O. E., et al.

Transfusion and Apheresis Science , vol.59, no.5, 2020 (SCI-Expanded)

72. Perinatal outcomes of 25 hiv-infected pregnant women: hacettepe university experience

İnkaya A. Ç., Örgül G., Halis N., Alp Ş., Kara A., Özyüncü Ö., et al.

Journal of the Turkish German Gynecological Association , vol.21, pp.180-186, 2020 (ESCI)

73. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome.

Göker H., Aladağ K., Demiroğlu H., Ayaz C., Büyükaşik Y., Inkaya A. Ç., et al.

Turkish journal of medical sciences , vol.50, no.4, pp.679-683, 2020 (SCI-Expanded)

74. May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?

Kara E., Inkaya A. Ç., Demirkan K.

International journal of antimicrobial agents , vol.55, pp.106003, 2020 (SCI-Expanded) Sustainable Development

75. Acute Loss-of-consciousness in Patient with Relapsing Candidemia and Bacteremia

Vural A. M., Arslan S., Erol T., İNKAYA A. Ç., Oguz K. K., UZUN Ö.

INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , vol.2, no.1, pp.52-53, 2020 (ESCI)

76. Cerrahi Alan İnfeksiyonlarının Profilaksisinde Lokal Vankomisin Uygulaması

KARA E., Bahap M., İNKAYA A. Ç., DEMİRKAN S. K., TOKGÖZOĞLU A. M., ÜNAL S.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.25, no.1, pp.19-27, 2020 (ESCI)

77. COVID-19: Immunopathogenesis

Mavi D., İNKAYA A. Ç.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.25, no.2, pp.121-131, 2020 (ESCI)

78. Temporal trends in the epidemiology of HIV in Turkey.

Erdinc F., Dokuzoguz B., Unal S., Komur S., Inkaya A. Ç., Inan D., et al.

Current HIV research , vol.18, pp.258-266, 2020 (SCI-Expanded) Sustainable Development

79. Local Vancomycin Usage for Prophylaxis of Surgical Site Infections

KARA E., BAHAP M., İNKAYA A. Ç., DEMİRKAN S. K., TOKGÖZOĞLU A. M., ÜNAL S.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.25, no.1, pp.19-27, 2020 (ESCI)

80. Visceral Leishmaniasis in A Patient Presenting with Fever of Unknown Origin: A Case Report From a Low-endemic Region of Turkey

jaiteh m., ÇALIK BAŞARAN N., ÖZIŞIK L., akman o., Hasanlı N., Tortop S., et al.

Turkish Journal of Parasitology , vol.43, no.4, pp.210-212, 2019 (Scopus)

81. Ultrastructural evaluation of urine alkalinization versus hydration on colistin-induced nephrotoxicity

Korucu B., Unal I., Pekcan M., İNKAYA A. Ç., Yeter H. H., ÇETİNKAYA M. A., et al.

Human and Experimental Toxicology , vol.38, no.12, pp.1366-1377, 2019 (SCI-Expanded)

82. Yoğun Bakım Hastalarında Antibiyotiklerin Diğer İlaçlarla Etkileşimlerinin Değerlendirilmesi

KARA E., TECEN YÜCEL K., ÖZDEMİR N., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.

STED/Sürekli Tıp Eğitimi Dergisi , vol.28, no.6, pp.404-409, 2019 (Peer-Reviewed Journal)

83. Splenic Actinomycosis in a Patient with Chronic Granulomatous Disease: A Case Report and Review of the Literature

AYAZ Ç. M., Hasanlı N., Demirci Duarte S., HAZIROLAN G., İNKAYA A. Ç., ÇİFTÇİ T. T., et al.

Infectious Diseases and Clinical Microbiology , vol.1, no.3, pp.158-164, 2019 (Peer-Reviewed Journal)

84. The Importance of Awareness for Malaria Regarding Prophylaxis and Early Diagnosis: Two Imported Malaria Cases in Turkey

ÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., Tortop S., Unalan T., BÖLEK H., ALTINTOP S. E., et al.

MIKROBIYOLOJI BULTENI , vol.53, no.4, pp.472-479, 2019 (SCI-Expanded)

85. Gastrocnemius muscle thickness as a predictor of sarcopenia in people living with HIV

Houssein M., İNKAYA A. Ç., Balci C., EŞME M., SÖNMEZER M. Ç., HALİL M. G., et al.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY , vol.22, pp.8, 2019 (SCI-Expanded) Sustainable Development

86. Role of Tumor Necrosis Factor alpha promoter polymorphisms in interferon related side effects in chronic hepatitis B patients under interferon alpha 2b treatment

İNKAYA A. Ç., TÜRK ARIBAŞ E., KANDEMİR B., Acar H., BİTİRGEN M.

Acta Medica , vol.50, no.2, pp.32-38, 2019 (Peer-Reviewed Journal)

87. Association of tumor necrosis factor alpha -238G/A and -308G/A promotor polymorphisms with clearance of Hepatitis B virus infection in Turkish population

İNKAYA A. Ç., TÜRK ARIBAŞ E., ERAYMAN İ., ACAR H., KANDEMİR B., BİTİRGEN M.

Acta Medica , vol.50, pp.1-6, 2019 (Peer-Reviewed Journal)

88. Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience

Kara E., İnkaya A. Ç., Aydın Haklı D., Demirkan S. K., Ünal S.

Turkish Journal Of Medical Sciences , vol.49, no.1, pp.222-229, 2019 (SCI-Expanded)

89. Comparison of Immunochromatographic (IC) and Real-time Polymerase Chain Reaction (Rt-PCR) Tests for Screening Neisseria gonorrhoeae, Chlamydia trachomatis, Ureaplasma spp. and Mycoplasma spp. in HIV-infected Men

Zarakolu P., ÇETİK S., İNKAYA A. Ç., ÜNAL S.

MIKROBIYOLOJI BULTENI , vol.53, no.1, pp.37-42, 2019 (SCI-Expanded) Sustainable Development

90. Predictors of unfavorable outcome in neurosyphilis: Multicenter ID-IRI Study

Ozturk-Engin D., Erdem H., Hasbun R., Wang S., Tireli H., Tattevin P., et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.38, no.1, pp.125-134, 2019 (SCI-Expanded) Sustainable Development

91. The investigation of Strongyloides stercoralis seroprevalence in immunosupressed patients in Turkey

KAYA F., İNKAYA A. Ç., Erteni A. I., ABBASOĞLU O., AKSOY S., AKYÖN YILMAZ Y., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.1, pp.16-19, 2019 (SCI-Expanded)

92. Determination of medication adherence and related factors among people living with HIV/AIDS in a Turkish university hospital

CEYLAN E., Koc A., İNKAYA A. Ç., ÜNAL S.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.1, pp.198-205, 2019 (SCI-Expanded)

93. Posaconazole prophylaxis in patients with acute myeloid leukemia: A real life experience from a prospective multicenter observational study

METAN G., Etgul S., Cifticioglu A., Saba R., KILIÇ A., Yilmaz H., et al.

MEDICAL MYCOLOGY , vol.56, 2018 (SCI-Expanded)

94. Invasive fungal diseases in patients with acute leukemia or allogeneic stem cell transplantion recepients: A prospective multicenter observational study

METAN G., Etgul S., Cifticioglu A., Saba R., KILIÇ A., Yilmaz H., et al.

MEDICAL MYCOLOGY , vol.56, 2018 (SCI-Expanded)

95. Neuroinvasive Listeriosis Could Petechial Hemorrhages be a Diagnostic Clue?

Diker S., OKAR S., Mehdikhanova L., ARSAVA E. M., KURNE A., CEVIK I. U., et al.

NEUROLOGIST , vol.23, no.3, pp.86-91, 2018 (SCI-Expanded)

96. An Unexpected Cause of Acute Enteritis in a Patient with Pure Red Cell Aplasia Parvovirus B19-Associated Acute Enteritis

KÖKLÜ H., BÜYÜKEREN B., İNKAYA A. Ç., SÖKMENSÜER C., KAV T.

AMERICAN JOURNAL OF GASTROENTEROLOGY , vol.113, no.4, pp.630-632, 2018 (SCI-Expanded)

97. Refractory Giardiasis in an Immunosuppressed Patient in Turkey

Kaya F., İNKAYA A. Ç., Macin S., Akyon Y., ERGÜVEN S.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.12, no.3, pp.204-207, 2018 (SCI-Expanded)

98. Evaluation of potential drug drug interactions on antiretroviral treatment

KARA E., İNKAYA A. Ç., Ozdemir N., Bayraktar-Ekincioglu A., Demirkan K., ÜNAL S.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, pp.307, 2018 (SCI-Expanded)

99. Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?

İNKAYA A. Ç., Demir N. A., Kolgelier S., Sumer S., Demir L. S., Ural O., et al.

MEDICINE , vol.96, no.36, 2017 (SCI-Expanded) Sustainable Development

100. Rare Tracheobronchitis Agent in a Patient with AIDS: Bordetella bronchiseptica

Macin S., Kittana F. N. A., İNKAYA A. Ç., Akyon Y., ÜNAL S.

JUNDISHAPUR JOURNAL OF MICROBIOLOGY , vol.10, no.7, 2017 (SCI-Expanded)

101. MP246IN VIVO EVALUATION OF PROTECTIVE EFFECT OF HYDRATION WITH SODIUM CHLORIDE VERSUS URINE ALKALINISATION ON COLISTIN INDUCED NEPHROTOXICITY IN RATS

KORUCU B., ÜNAL ı., PEKCAN M., ÇETİNKAYA M. A., KAYMAZ F. F., İNKAYA A. Ç., et al.

Nephrology Dialysis Transplantation , vol.32, pp.516-517, 2017 (SCI-Expanded)

102. IN VIVO EVALUATION OF PROTECTIVE EFFECT OF HYDRATION WITH SODIUM CHLORIDE VERSUS URINE ALKALINISATION ON COLISTIN INDUCED NEPHROTOXICITY IN RATS

Korucu B., Unal I., Pekcan M., ÇETİNKAYA M. A., KAYMAZ F. F., İNKAYA A. Ç., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.32, 2017 (SCI-Expanded)

103. Impaired Thiol-Disulfide Balance in Acute Brucellosis

Kolgelier S., ERGİN M., Demir L. S., İNKAYA A. Ç., Demir N. A., Alisik M., et al.

JAPANESE JOURNAL OF INFECTIOUS DISEASES , vol.70, no.3, pp.258-262, 2017 (SCI-Expanded)

104. ÇALIŞMA HAYATI VE VİRAL HEPATİTLER

ECİN S. M., İNKAYA A. Ç., YILDIZ A. N.

TÜRK TABİPLERİ BİRLİĞİ MESLEKİ SAPLIK VE GÜVENLİK DERGİSİ , 2017 (Peer-Reviewed Journal)

105. Mastoiditis, Brain Abscess and Sinus Thrombosis As Complications of Chronic Otitis Media: A Case Report

Macin S., İNKAYA A. Ç., Dogan O., BOZKURT G., GÖÇMEN R., SARDAN Y. C., et al.

JUNDISHAPUR JOURNAL OF MICROBIOLOGY , vol.10, no.2, 2017 (SCI-Expanded)

106. Evaluation of antibiotic drug interactions in intensive care unit

KARA E., Tecen K., Ozdemir N., İNKAYA A. Ç., Bayraktar-Ekincioglu A., Demirkan K., et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.39, no.1, pp.290-291, 2017 (SCI-Expanded)

107. Actinomyces-associated Lesions Located in the Gingiva: Case Report of Rare Gingival Lesions

ACAR B., ÇAĞLAYAN F., İNKAYA A. Ç., KURTULAN O.

CONTEMPORARY CLINICAL DENTISTRY , vol.8, no.1, pp.182-184, 2017 (ESCI)

108. Nefes Darlığı ve Ateşle Başvuran HIV Pozitif Hasta

İNKAYA A. Ç., ORTAÇ ERSOY N. E., ÖCAL S., ÜNAL S.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.21, no.4, pp.182-185, 2016 (Peer-Reviewed Journal) Sustainable Development

109. Keyif Verici Maddeler ve Antiretroviraller Keyfi dünyaya mı bedel yoksa keyfe mi keder

KARA E., İNKAYA A. Ç., DEMİRKAN S. K., ÜNAL S.

Mediterranean Journal of Infection, Microbes and Antimicrobials , vol.5, no.11, 2016 (ESCI)

110. DIRECT COST OF HIV/AIDS IN TURKEY

Tatar M., Kockaya G., Ozelgun B., Elbir Z. T., Senturk A., Tuna E., et al.

VALUE IN HEALTH , vol.19, no.7, 2016 (SCI-Expanded) Sustainable Development

111. INDIRECT COST OF HIV/AIDS: RESULTS OF A SURVEY FROM A TURKISH RESEARCH CENTER

Tatar M., Kockaya G., Ozelgun B., Elbir Z. T., Senturk A., Tuna E., et al.

VALUE IN HEALTH , vol.19, no.7, 2016 (SCI-Expanded) Sustainable Development

112. Infections related to Granulicatella adiacens: Report of two cases and review of literature

MACIN S., İNKAYA A. Ç., TUNCER O. O., ÜNAL S., Akyon Y.

INDIAN JOURNAL OF MEDICAL MICROBIOLOGY , vol.34, no.4, pp.547-550, 2016 (SCI-Expanded)

113. A really family physicians aware of Hepatitis B?

DEMİR L. S., AKTUĞ DEMİR N., İNKAYA A. Ç., GÜLER S., ŞAHİN HORASAN E., KOLGELIER S., et al.

International Journal of Collaborative Research on Internal Medicine Public Health , vol.8, pp.593-602, 2016 (SCI-Expanded) Sustainable Development

114. Are Really Family Physicians Aware of Hepatitis B?

Demir L. S., Demir N. A., İNKAYA A. Ç., Guler S., Horasan E. S., Kolgelier S., et al.

INTERNATIONAL JOURNAL OF COLLABORATIVE RESEARCH ON INTERNAL MEDICINE & PUBLIC HEALTH , vol.8, no.10, pp.593-602, 2016 (Peer-Reviewed Journal) Sustainable Development

115. Evaluation of PNA-FISH Method for Direct Identification of Candida Species in Blood Culture Samples and Its Potential Impact on Guidance of Antifungal Therapy

Dogan O., İNKAYA A. Ç., Gulmez D., UZUN Ö., AKOVA M., ARIKAN AKDAĞLI S.

MIKROBIYOLOJI BULTENI , vol.50, no.4, pp.580-589, 2016 (SCI-Expanded)

116. An Unusual Case of Tuberculosis Lenfadenitis Mimicking Tularemia

Başpınar B., HELVACI Ö., GÜVEN D. C., İNKAYA A. Ç.

Turkiye Klinikleri Journal of Internal Medicine , vol.1, no.2, pp.111-113, 2016 (Peer-Reviewed Journal)

117. Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy

ÇULHA M. G., İNKAYA A. Ç., YİLDİRİM E., ÜNAL S., ŞEREFOĞLU E. C.

MEDICAL HYPOTHESES , vol.94, pp.151-153, 2016 (SCI-Expanded)

118. Severe measles pneumonia in adults with respiratory failure: role of ribavirin and high-dose vitamin A

Ersoy E. O., Tanriover M. D., ÖCAL S., ÖZIŞIK L., Inkaya C., Topeli A.

CLINICAL RESPIRATORY JOURNAL , vol.10, no.5, pp.673-675, 2016 (SCI-Expanded, Scopus) Sustainable Development

119. Aggregatibacter aphrophilus misidentified as Brucella spp in an immunocompetent patient with brain abscess

İNKAYA A. Ç., MACİN S., BOZKURT G., GÖÇMEN R., AKYÖN YILMAZ Y., ÜNAL S.

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION , vol.66, pp.1032-1034, 2016 (SCI-Expanded)

120. A Case of Extensive Wound Myiasis Caused by Lucilia sericata (Diptera: Calliphoridae) in a Patient with Maxillary Sinus Squamous Cell Carcinoma, in Turkey

Demirel-Kaya F., ORKUN Ö., ÇAKMAK A., İNKAYA A. Ç., ÖCAL M., ERGÜVEN S.

JOURNAL OF ARTHROPOD-BORNE DISEASES , vol.10, no.2, pp.268-271, 2016 (SCI-Expanded) Sustainable Development

121. Which HIV patients should be screened for osteoporosis: an international perspective

Alvarez E., Belloso W. H., Boyd M. A., İNKAYA A. Ç., HSİEH E., KAMBUGU A., et al.

CURRENT OPINION IN HIV AND AIDS , vol.11, no.3, pp.268-276, 2016 (SCI-Expanded) Sustainable Development

122. [Plasmodium falciparum malaria: evaluation of three imported cases].

İNKAYA A. Ç., KAYA F., YıLDıZ İ., UZUN Ö., Ergüven S.

Mikrobiyoloji bulteni , vol.50, pp.328-32, 2016 (SCI-Expanded) Sustainable Development

123. Plasmodium falciparum Malaria: Evaluation of Three Imported Cases

İNKAYA A. Ç., Kaya F., Yildiz I., UZUN Ö., ERGÜVEN S.

MIKROBIYOLOJI BULTENI , vol.50, no.2, pp.328-332, 2016 (SCI-Expanded) Sustainable Development

124. Recreational Drugs and Antiretrovirals: Is It Worth the World or Trivial?

KARA E., İNKAYA A. Ç., Demirkan K., ÜNAL S.

MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS , vol.5, 2016 (ESCI)

125. Evaluation of 255 HIV/AIDS Cases: Hacettepe Cohort, Ankara, Turkey

CERCI P., İNKAYA A. Ç., Alp Ş., TÜMER A., ÜNAL S.

MIKROBIYOLOJI BULTENI , vol.50, no.1, pp.94-103, 2016 (SCI-Expanded) Sustainable Development

126. Serum Levels of Annexin A2 as a Candidate Biomarker for Hepatic Fibrosis in Patients With Chronic Hepatitis B

Kolgelier S., Demir N. A., İNKAYA A. Ç., Sumer S., OZCIMEN S., Demir L. S., et al.

HEPATITIS MONTHLY , vol.15, no.10, 2015 (SCI-Expanded)

127. Conjunctival Flora in Diabetic and Nondiabetic Individuals

ADAM M., BALCI M., BAYHAN H. A., İNKAYA A. Ç., UYAR M., GÜRDAL C.

Türk Oftalmoloji Dergisi , vol.45, pp.193-196, 2015 (Peer-Reviewed Journal) Sustainable Development

128. Cytomegalovirus (CMV) Infections in Patients with Rheumatic Diseases: Experience of a Referral Center

ŞENER Y. Z., AKTAŞ B. Y., Erden A., KILIÇ L., Armagan B., İNKAYA A. Ç., et al.

ARTHRITIS & RHEUMATOLOGY , vol.67, 2015 (SCI-Expanded)

129. A rare case of longitudinal Brucella myelitis.

ONDER H., Gocmen R., INKAYA A. Ç., Temucin C.

The spine journal : official journal of the North American Spine Society , vol.15, pp.1689-90, 2015 (SCI-Expanded)

130. The clinical features, diagnosis, treatment, and prognosis of neuroinvasive listeriosis: a multinational study

Arslan F., MEYNET E., Sunbul M., SİPAHİ O. R., KURTARAN B., KAYA S., et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.34, no.6, pp.1213-1221, 2015 (SCI-Expanded) Sustainable Development

131. Knowledge Level of Hepatitis B and its Prevalance in Policemen Working in Adiyaman

KOLGELIER S., AKTUĞ DEMİR N., DEMİR L. S., OZCIMEN S., İNKAYA A. Ç.

European Journal of General Medicine , vol.12, pp.114-117, 2015 (Peer-Reviewed Journal) Sustainable Development

132. Ongoing Activity of Toscana Virus Genotype A and West Nile Virus Lineage 1 Strains in Turkey: A Clinical and Field Survey

ÖCAL M. T., ÖRSTEN S., İNKAYA A. Ç., YETIM E., ACAR N., ALP S., et al.

ZOONOSES AND PUBLIC HEALTH , vol.61, no.7, pp.480-491, 2014 (SCI-Expanded)

133. Serum annexin A2 levels in acute brucellosis and brucellar spondylodiscitis

Demir N. A., Kolgelier S., Sumer S., İNKAYA A. Ç., OZCIMEN S., Demir L. S., et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.33, no.10, pp.1855-1859, 2014 (SCI-Expanded)

134. The Knowledge and Behavior of Hairdressers and Barbers on Blood-Borne Diseases

AKTUĞ DEMİR N., KOLGELIER S., DEMİR L. S., OZCIMEN S., İNKAYA A. Ç.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.20, pp.67-71, 2014 (Peer-Reviewed Journal)

135. Diagnostic clues for spondylitis in acute brucellosis

Aktug-Demir N., Kolgelier S., OZCIMEN S., Sumer S., Demir L. S., İNKAYA A. Ç.

SAUDI MEDICAL JOURNAL , vol.35, no.8, pp.816-820, 2014 (SCI-Expanded)

136. Kliniko-patolojik olgu tart›flmas›:Sistemik lupus eritematosus

AKTAŞ B. Y., KALYONCU U., İNKAYA A. Ç., TUNCER M. A., ARSAVA E. M., KARLI OĞUZ H. K.

RAED dergisi , vol.6, no.1, pp.36-41, 2014 (Peer-Reviewed Journal)

137. Are bone morphogenetic protein-7 (BMP-7) serum levels correlated with development of hepatic fibrosis?

Demir N. A., Kolgelier S., İNKAYA A. Ç., Sumer S., Demir L. S., PEHLIVAN F. S., et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.8, no.5, pp.605-610, 2014 (SCI-Expanded)

138. Cutanous Myiasis Caused by Sarcophaga spp. Larvae in a Diabetic Patient

Demirel Kaya F., Orkun O., Cakmak A., İNKAYA A. Ç., ERGÜVEN S.

MIKROBIYOLOJI BULTENI , vol.48, no.2, pp.356-361, 2014 (SCI-Expanded)

139. Evaluation of the Relation Between Hepatic Fibrosis and Basic Laboratory Parameters in Patients With Chronic Hepatitis B Fibrosis and Basic Laboratory Parameters

Demir N. A., Kolgelier S., OZCIMEN S., GUNGOR G., Sumer S., Demir L. S., et al.

HEPATITIS MONTHLY , vol.14, no.4, 2014 (SCI-Expanded)

140. Diyabetik Bir Hastada Sarcophaga spp.Larvalarının Neden Olduğu Kutanöz Miyazis

DEMİREL KAYA S., ORKUN Ö., İNKAYA A. Ç., ÇAKMAK A., ERGÜVEN S.

Mikrobiyoloji Bulteni , vol.48, pp.356-361, 2014 (SCI-Expanded) Sustainable Development

141. Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria

Petrosillo N., GIANNELLA M., ANTONELLI M., ANTONINI M., BARSIC B., BELANCIC L., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.58, no.2, pp.851-858, 2014 (SCI-Expanded)

142. Mortality indicators in pneumococcal meningitis: therapeutic implications

ERDEM H., ELALDI N., OZTOPRAK N., SENGOZ G., AK O., KAYA S., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.19, pp.13-19, 2014 (SCI-Expanded)

143. Comparison of the Level of Depression and Anxiety in Inactive Hepatitis B Carriers and Chronic Hepatitis B Patients

Demir N. A., Celik M., Kolgelier S., Sumer S., Aksoz S., Demir L. S., et al.

TURK PSIKIYATRI DERGISI , vol.24, no.4, pp.248-252, 2013 (SSCI) Sustainable Development

144. Kocuria rosea’xxnın Neden Olduğu Bakteremi ve Menenjit: Olgu Sunumu

İNKAYA A. Ç., AKTUĞ DEMİR N., UĞUR G., GÜMÜŞ H., YILMAZ TATAR E.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.18, no.3, pp.149-152, 2013 (Peer-Reviewed Journal)

145. LEVEL OF KNOWLEDGE AND COMPLIANCE TO HAND HYGIENE AMONG HEALTH CARE WORKERS

Demir N. A., Kolgelier S., Kucuk A., OZCIMEN S., SONMEZ B., DEMIR L. S., et al.

NOBEL MEDICUS , vol.9, no.3, pp.104-109, 2013 (SCI-Expanded)

146. SAĞLIK ÇALIŞANLARININ El HİJYENİ HAKKINDAKİ BİLGİ DÜZEYİ VE El HİJYENİNE UYUMU

AKTUĞ DEMİR N., KOLGELIER S., KUCUK A., OZCIMEN S., SONMEZ B., DEMİR L. S., et al.

Nobel Medicus , vol.9, pp.104-109, 2013 (SCI-Expanded)

147. The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis

Sumer S., DEMIR N. A., Kolgelier S., İNKAYA A. Ç., Arpaci A., DEMIR L. S., et al.

HEPATITIS MONTHLY , vol.13, no.6, 2013 (SCI-Expanded)

148. NAİF KRONİK HEPATİT B HASTALARININ BİR YILLIK 245 MG/GÜN TENOFOVİR DİSOPROKSİL FUMARATE TEDAVİ SONUÇLARININ DEĞERLENDİRİLMESİ

AKTUĞ DEMİR N., KOLGELIER S., DEMİR L. S., SÜMER Ş., DIKICI N., OZCIMEN S., et al.

Nobel Medicus , vol.9, pp.57-62, 2013 (SCI-Expanded) Sustainable Development

149. EVALUATION OF ONE YEAR RESPONSE OF TREATMENT NAIVE CHRONIC HEPATITIS B PATIENTS TO 245 MG/DAY TENOFOVIR DISOPROXIL FUMARATE

DEMIR N. A., KOLGELIER S., DEMIR L. S., SUMER S., DIKICI N., OZCIMEN S., et al.

NOBEL MEDICUS , vol.9, no.2, pp.57-62, 2013 (SCI-Expanded) Sustainable Development

150. Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey

AKSU H. Z., KURTARAN B., Onlen Y., Namiduru M., Inkaya A. Ç., Kandemir O., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.24, no.12, pp.1393-1399, 2012 (SCI-Expanded) Sustainable Development

151. Hypophosphatemia Due to Adefovir Treatment

Demir N. A., Kolgelier S., Ozcimen S., Aksoz S., Inkaya A. C.

MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS , vol.1, 2012 (ESCI) Sustainable Development

152. Kemoterapi Alan Hastalarda Hepatit B Reaktivasyonu

ARTAÇ M., EREN O. Ö., Börüban M. C., İNKAYA A. Ç.

Viral Hepatit Dergisi , vol.16, no.2, pp.69-76, 2010 (ESCI) Sustainable Development

Papers Presented at Peer-Reviewed Scientific Conferences 80

1. Erişkin kistik fibrozis hastalarında meropenem ilaç düzeyi izlemi

AKMAN AR E. D., YALÇIN N., KARA E., İNKAYA A. Ç., DAMADOĞLU E., KALYONCU A. F., et al.

Türk Toraks Derneği 27. Kongresi, Girne, Cyprus (Kktc), 29 April - 03 May 2024, (Summary Text)

2. SS-015 EGZERSİZ ALIŞKANLIĞI HIV İLE YAŞAYAN BİREYLERİN BİYOPSİKOSOSYAL ÖZELLİKLERİNİ ETKİLER Mİ?

BURAN S., Tüfekçi O., KARACA N. B., SÖNMEZER M. Ç., İNKAYA A. Ç., ÜNAL S., et al.

25. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, pp.43, (Summary Text)

3. ERİŞKİN İMMÜNYETMEZLİKLİ HASTALARDA SAĞLIKLA İLİŞKİLİ YAŞAM KALİTESİ VE ÇALIŞMA DURUMLARININ BELİRLENMESİ

MADEN S., ÖZDEDE M., ÖZDEMİRAL C., ESENBOĞA S., SÖNMEZER M. Ç., İNKAYA A. Ç., et al.

25. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Turkey, 8 December - 12 November 2023, (Full Text)

4. HIV ile yaşayan bireylerin kırılganlık düzeyine göre yaşam kalitesi, anksiyete, depresyon ve biyopsikososyal durumlarının karşılaştırılması

BURAN S., Tüfekçi M. O., SÖNMEZER M. Ç., İNKAYA A. Ç., ÜNAL E., ÜNAL S.

HIV/AIDS Kongresi 2022, Antalya, Turkey, 24 November 2022, (Summary Text)

5. Antiretroviral therapy causes a reduction in T-cell exhaustion, which is preserved after switching to a new therapy regimen

Özcan B., Tavukçuoğlu E., KARA E., Horzum U., AYAN G., SÖNMEZER M. Ç., et al.

18th European AIDS Conference (EACS 2021), London, Canada, 27 October 2021, vol.1, pp.52-53, (Full Text)

6. COVID-19 Tanısı ile Servis ve Yoğun Bakım Ünitelerinde İzlenen Hastaların İmmünolojik Özelliklerinin Karşılaştırılması

ÇALIK BAŞARAN N., TAN Ç., UYAROĞLU O. A., DEĞİRMENCİLER R. F., TELLİ DİZMAN G., ÖZBEK B., et al.

23. Ulusal İç Hastalıkları Kongresi, Girne, Cyprus (Kktc), 06 October 2021, pp.38-39, (Summary Text)

7. Seasonal human coronaviruses (sHCoVs) circulation among adults before COVID-19 pandemic at a tertiary care hospital in Turkey

SÖNMEZER M. Ç., RUDVAN AL L. İ., TELLİ DİZMAN G., ALP A., İNKAYA A. Ç., ÖZYAVUZ ALP Ş., et al.

31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2021, viyana, Austria, 9 - 12 July 2021, (Summary Text) Sustainable Development

8. HIV İle Yaşayan Kadınların Cinsel Sağlık ve Üreme Sağlığı İle İlgili Bilgi Ve Tutumlarına HIV İle Yaşamanın Etkisinin Değerlendirilmesi

MIHCI Ö., AYHAN BAŞER D., SÖNMEZER M. Ç., CANKURTARAN M., İNKAYA A. Ç., ÜNAL S.

Ulusal Aile Hekimliği Kongresi 2020 (19. Ulusal Aile Hekimliği Kongresi), Online, Turkey, 29 October - 01 November 2020, pp.330, (Full Text)

9. HIV enfeksiyonu tedavisinde nelere dikkat etmeliyiz?

İNKAYA A. Ç.

BUHASDER KONGRESİ 2019, İzmir, Turkey, 16 - 20 October 2019, (Full Text) Sustainable Development

10. HIV ve İnflamasyon

İNKAYA A. Ç.

HIV/AIDS Kampı 2019, Malatya, Turkey, 11 - 13 October 2019, (Full Text) Sustainable Development

11. BK virus can be neurotropic: a rare cause of PML

AYVACIOĞLU C., KARABUDAK R., TUNCER A., ÖGE D. D., ELİBOL B., Tan E., et al.

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11 - 13 September 2019, vol.25, pp.836, (Summary Text)

12. Gastrocnemius Muscle Thickness as a predictor of Sarcopenia in People Living with HIV

Houssein M., İNKAYA A. Ç., BALCI C., EŞME M., SÖNMEZER M. Ç., HALİL M. G., et al.

10th International Conference on HIV Sciences, Mexico City, Mexico, 21 - 24 July 2019, vol.22, pp.25327, (Summary Text)

13. EARLY CESSATION OF EMPIRICAL ANTIBACTERIAL THERAPY IN HIGH-RISK FEBRILE NEUTROPENIC PATIENTS WITH FEVER OF UNKNOWN ORIGIN (FUO)

KORUCU B., İNKAYA A. Ç., ERBİL A., OKAY M., AŞÇIOĞLU S., TOKUÇOĞLU ALTUNAY H., et al.

20TH SYMPOSIUM ON INFECTIONS IN THE IMMUNOCOMPROMISED HOST, ATİNA, Greece, 17 - 19 July 2019, pp.76, (Summary Text)

14. Evaluation of Chronic Hepatitis B Patients’xx Knowledge About Their Disease

Bahap M., KARA E., SÖNMEZER M. Ç., İNKAYA A. Ç., DEMİRKAN S. K., ÜNAL S.

International Forum on Infectious Diseases, İstanbul, Turkey, 21 - 24 March 2019, (Summary Text) Sustainable Development

15. Comparison of immunochromatographic and real-time polimerase chain reaction tests for screening Neisseria gonorrhoeae, Chlamydia trachomatis, Ureaplasma spp., Mycoplasma spp. in HIV-infected men

ZARAKOLU KÖŞKER I. P., cetik s., İNKAYA A. Ç., ÜNAL S.

29th ECCMID, 13 - 16 April 2019, (Full Text)

16. Drug Interactions of Echinocandins In Patients with Candidemia

KARA E., BALLI F. N., KANDEMİR E. A., İNKAYA A. Ç., ÖZYAVUZ ALP Ş., DEMİRKAN S. K.

International Forum on Infectious Diseases 2019 (IFID 2019), 21 - 24 March 2019

17. Evaluation of Chronic Hepatitis B Patients’ Knowledge About Their Disease

BAHAP M., KARA E., SÖNMEZER M. Ç., İNKAYA A. Ç., DEMİRKAN S. K., ÜNAL S.

International Forum on Infectious Diseases 2019 (IFID 2019), 21 - 24 March 2019 Sustainable Development

18. Ciddi Kronik Nötropeni ile Başvuran Adenozin Deaminaz Tip II Eksikliği Olan İki Olgu

ÇAĞDAŞ AYVAZ D. N., SÜLEYMAN M., OCAK M., TAN Ç., GÜR ÇETİNKAYA P., İNKAYA A. Ç., et al.

5. klinik immünoloji Kongresi, Antalya, Turkey, 20 - 23 March 2019, (Summary Text)

19. Hematopoietic Stem Cell Transplantation for HIV-positive Patients with Hematologic MAlignancies: Three Patients Experience from Turkey

Çiftçiler R., GÖKER H., İNKAYA A. Ç., ÜNAL S., DEMİROĞLU H.

International Forum on Infectious Diseases, İstanbul, Turkey, 21 - 24 March 2019, pp.11-14, (Full Text) Sustainable Development

20. Hıv ile yaşayan kişilerde sarkopeni taramasında gastroknemius kas kalınlığının rolü

HOUSSEİN m., İNKAYA A. Ç., BALCI C., EŞME M., SÖNMEZER M. Ç., HALİL M. G., et al.

HIV/AIDS KONGRESİ, Turkey, 15 - 18 November 2018, (Full Text)

21. Psikiyatrist ve Enfeksiyon Hastalıkları Hekimlerinin İlaç-İlaç Etkileşimleri Konusunda Tutumları

KARA E., YALÇIN N., İNKAYA A. Ç., BAŞAR K., DEMİRKAN S. K., ÜNAL S.

HIV/AIDS Kongresi 2018, Turkey, 15 - 18 November 2018, (Summary Text)

22. HIV pozitif hastalarda Nörokognitif Kırılganlığın Belirlenmesi ve Fiziksel Kırılganlıkla İlişkisi

Houssein M., İNKAYA A. Ç., BALCI C., EŞME M., SÖNMEZER M. Ç., HALİL M. G., et al.

HIV/AIDS Kongresi 2018, Turkey, 15 - 18 November 2018, (Summary Text) Sustainable Development

23. The importance of awareness for malaria regarding prophylaxis and early diagnosis: two important malaria cases in Turkey

ÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., TORTOP s., ÜNALAN E. T., BÖLEK h., ALTINTOP S. E., et al.

XXXVIII. turkish Microbiology Congress, 4 - 08 November 2018, (Full Text) Sustainable Development

24. Cystoisospora belli infection in renal transplant recipient in a university hospital

ÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., Tortop S., ÜNALAN E. T., Bölek H., ALTINTOP S. E., et al.

Uluslararası 38. Türk Mikrobiyoloji Kongresi, 4 - 08 November 2018, (Summary Text)

25. The İmportance of Awareness for MAlaria Regarding Prophylaxis and Early Diagnosis: Two Imported Malaria Cases in Turkey

ÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., Tortop S., ÜNALAN E. T., Bölek H., ALTINTOP S. E., et al.

Uluslararası 38. Türk Mikrobiyoloji Kongresi, 4 - 08 November 2018, (Summary Text) Sustainable Development

26. Concomitant Herpes Simplex and Cytomegalovirus Reactivations in a Mycosis Fungoides Patient under Romidepsin Treatment: A Case Report

İNKAYA A. Ç., DOĞAN GÜNAYDIN S., ÖZYAVUZ ALP Ş., AKOVA M.

20th ICHS Symposium on Infections in the Immunocompromised Host, 17 - 19 June 2018, (Summary Text)

27. POST-TRANSPLANT EBSTEIN-BARR VIRAL LOAD MONITORING EXPERIENCE IN A HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER

AYDIN M. S., İNKAYA A. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., TURGUT M., GÖKER H., et al.

23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018, (Summary Text)

28. Hekimlerin Antiretroviral ve Psikotrop İlaçlar Arasındaki Etkileşimlere Yaklaşımı (SS-017).

yalcin N., KARA E., basar K., İNKAYA A. Ç., DEMİRKAN S. K., ÜNAL S.

7. Türkiye EKMUD Uluslararasi Kongresi, Antalya, Turkey, 8 - 13 May 2018, vol.7, pp.25, (Full Text)

29. Hekimlerin Antiretroviral ve Psikotrop İlaçlar ArasındakiEtkileşimlere Yaklaşımı

YALÇIN N., KARA E., BAŞAR K., İNKAYA A. Ç., DEMİRKAN S. K., ÜNAL S.

7. Türkiye Ekmud Uluslararası Kongresi, Antalya, Turkey, 8 - 13 May 2018, (Summary Text)

30. HIV ile enfekte kişide dev anogenital kondilom : Olgu Sunumu

TAŞ Z., SÖNMEZER M. Ç., İNKAYA A. Ç., KÖSEMEHMETOĞLU K., AKİ t., ÜNAL S.

XIX. KLİMİK Kongresi, 28 - 31 March 2018, (Summary Text) Sustainable Development

31. HIV/HCV Koenfeksiyonu: Zor Olgu Yönetimi

SÖNMEZER M. Ç., İNKAYA A. Ç., ÖZYAVUZ ALP Ş., ÜNAL S.

İNFEKSİYON Dünyası ÇALIŞTAYI, Turkey, 22 - 25 March 2018, (Summary Text) Sustainable Development

32. Hızla İlerleyen Bir Rinoserebral Mukormikoz Olgusu.

DEMİRCİ S., TOKUÇOĞLU ALTUNAY H., İNKAYA A. Ç., LİSTE Ü., SIĞ A. K., GÜLMEZ KIVANÇ D., et al.

İnfeksiyon Dünyası Çalıştayı, Ankara, Turkey, 22 - 25 March 2018, (Summary Text)

33. HIV/HCV KO-ENFEKSİYONU: ZOR OLGU YÖNETİMİ

SÖNMEZER M. Ç., İNKAYA A. Ç., ÖZYAVUZ ALP Ş., TÜMER A., ÜNAL S.

İNFEKSİYON DÜNYASI ÇALIŞTAYI 2018, Ankara, Turkey, 22 - 25 March 2018, (Summary Text) Sustainable Development

34. HIV İnfekte Kişide Anal Lezyon Tanı ve Takibi

TOKCUOGLU h., KÖKLÜ h., SÖKMENSÜER c., İNKAYA A. Ç., KAV T., ÜNAL S.

HIV/AIDS Asistan Okulu, Antalya, Turkey, 9 - 11 February 2018, (Summary Text) Sustainable Development

35. ANTİRETROVİRAL TEDAVİDE POTANSİYEL İLAÇ-İLAÇ ETKİLEŞİMLERİNİN DEĞERLENDİRİLMESİ

İNKAYA A. Ç., DEMİRKAN S. K., ÜNAL S.

HIV/AIDS KONGRESİ 2017, Antalya, Turkey, 16 - 19 November 2017, (Summary Text)

36. SALMONELLA GRUP D’NİN NEDEN OLDUĞU SEPTİK ARTRİT OLGUSU

KARDAŞ R. C., BIÇAKCIGİL A., ERDUT A., ÇİÇEK M., LİSTE Ü., ALTUN B., et al.

4 ULUSAL KLİNİK MİKROBİYOLOJİ KONGRESİ, Turkey, 8 - 12 November 2017, (Summary Text)

37. Bağışıklık sistemi baskılanmış hastalarda Microsporidia ve fırsatçı bağırsak parazitlerinin varlığının araştırılması

Kaya F., İNKAYA A. Ç., AKSOY S., ABBASOĞLU O., ERTENLİ A. İ., BÜYÜKAŞIK Y., et al.

4. Ulusal Klinik Mikrobiyoloji Kongresi, Turkey, 8 - 12 November 2017, (Summary Text)

38. Evaluation of potential drug drug interactions on antiretroviral treatment

KARA E., İNKAYA A. Ç., ÖZDEMİR N., bayraktar a., DEMİRKAN S. K., ÜNAL S.

46th ESCP symposium on clinical pharmacy “Science meetspractice: towards evidence-based clinical pharmacy services”, Heidelberg, Germany, 9 - 11 October 2017, vol.40, pp.203-317, (Full Text)

39. Comparison of Risk Category Predictions of Framingham Risk Score (FRS), Atherosclerotic Cardiovascular Disease Risk Score (ASCVD), Systematic Coronary Risk Evaluation (SCORE) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) in HIV Infected Patients.

KORTEN V., GÖKENGİN A. D., YILDIRMAK T., İNKAYA A. Ç., FİNCANCI m., YAĞCI ÇAĞLAYIK d., et al.

IDWeek 2017, 4 - 08 October 2017, (Summary Text) Sustainable Development

40. Drug Related Problems and Polypharmacy Are Common Among People Living with HIV/AIDS

Kara E., İnkaya A. Ç., Özdemir N., Tecen Yücel K., Aydın Haklı D., Ekincioğlu A., et al.

9th IAS Conference on HIV Science, Paris, France, 23 - 26 July 2017, pp.442, (Summary Text) Sustainable Development

41. Ageing with HIV (including polypharmacy and frailty) Drug related problems and polypharmacy are common among people living with HIV/AIDS

KARA E., İNKAYA A. Ç., ÖZDEMİR N., TECEN YÜCEL K., AYDIN HAKLI D., BAYRAKTAR EKİNCİOĞLU A., et al.

IAS2017 9th Conference on HIV Science, 23 - 26 June 2017, (Full Text) Sustainable Development

42. In vivo evaluation of protective effect of hydration with sodium chloride versus urine

KORUCU B., ünal ı., PEKCAN M., ÇETİNKAYA M. A., KAYMAZ F. F., HAYRAN K. M., et al.

54th era-edta congress, 3 - 06 June 2017, (Full Text)

43. IN VIVO EVALUATION OF PROTECTIVE EFFECT OF HYDRATION WITH SODIUM CHLORIDE VERSUS URINE ALKALINISATION ON COLISTIN INDUCED NEPHROTOXICITY IN RATS

KORUCU B., ÜNAL I., PEKCAN M., ÇETİNKAYA M. A., KAYMAZ F. F., İNKAYA A. Ç., et al.

54th ERA-EDTA CONGRESS, Madrid, Spain, 3 - 06 June 2017, (Summary Text)

44. Can urine alkalinisation be a treatment option on colistin induced nephrotoxicity: an ultrastructural and histochemical study on rats

KORUCU B., ÜNAL I., PEKCAN M., ÇETİNKAYA M. A., KAYMAZ F. F., HAYRAN K. M., et al.

15th International Congress of Histochemistry and Cytochemistry (ICHC 2017) in Antalya, 18 - 21 May 2017, (Summary Text)

45. HIV/AIDS ile yaşayan hastalarda polifarmasi

KARA E., ÖZDEMİR N., TECEN YÜCEL K., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.

4. Ulusal Hastane ve Kurum Eczacıları Kongresi, Muğla, Turkey, 8 - 12 March 2017, pp.29, (Summary Text) Sustainable Development

46. Zeytinyağlı yiyemem aman

TOKUÇOĞLU ALTUNAY H., İNKAYA A. Ç., ÜNAL S.

Hıv Aıds Tedavide Yenilikler ve Altta Yatan Hastalıklar, Turkey, 18 February 2017, (Full Text)

47. HIV/AIDS ile Yaşayan Hastalarda Polifarmasi ve İlaç Kaynaklı Problemler

KARA E., İNKAYA A. Ç., ÖZDEMİR N., TECEN YÜCEL K., AYDIN HAKLI D., EKİNCİOĞLU A., et al.

3.Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Antalya, Turkey, 9 - 12 February 2017, pp.49-50, (Summary Text) Sustainable Development

48. Evaluation of Antibiotics Drug İnteraction in Intensive Care Unit

KARA E., TECEN YÜCEL K., ÖZDEMİR N., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.

45th ESCP Annual Symposium Clinical pharmacy tackling inequalities and access to health care, Norway, 5 - 07 October 2016, (Summary Text)

49. Listeria rhomboensefalit Farklı yüzler farklı tarzlar

AKOVA M., GÖÇMEN R., KARLI OĞUZ H. K., MUT AŞKUN M., TOPÇUOĞLU M. A., ÜNAL ÇEVİK I., et al.

52. Ulusal Nöroloji Kongresi, Turkey, 25 November - 01 December 2016

50. Evaluation of Antibiotic Drug Interactions in Intensive Care Unit

KARA E., TECEN K., ÖZDEMİR N., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.

45.European Symposium on Clinical Pharmacy, Oslo, Norway, 5 - 07 October 2016, vol.39, pp.290-291, (Summary Text)

51. Drug Drug Interactions of Antibiotics and Other Drugs in Intensive Care Unit

KARA E., TECEN K., ÖZDEMİR N., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.

45TH ESCP ANNUAL SYMPOSIUM CLINICAL PHARMACY, 5 - 07 October 2016, (Summary Text)

52. A Major Concern Among HIV AIDS Patients Polypharmacy

KARA E., ÖZDEMİR N., TECEN K., İNKAYA A. Ç., EKİNCİOĞLU A., DEMİRKAN S. K., et al.

INTERNATIONAL WORKSHOP ON HEALTHY LIVING WITH HIV, 2 - 03 September 2016, (Summary Text) Sustainable Development

53. Yoğun Bakım Hastalarında Antibiyotiklerin Diğer İlaçlarla Etkileşimlerinin Değerlendirilmesi

KARA E., TECEN K., ÖZDEMİR N., İNKAYA A. Ç., ÖCAL S., ORTAÇ ERSOY N. E., et al.

Hastane İnfeksiyonları Kongresi 2016, Turkey, 30 March - 03 April 2016, (Summary Text)

54. Hacettepe Üniversitesi Tıp Fakültesi Erişkin Hastanesi İnfeksiyon Hastalıkları Kliniğinde İzlenen HIV Olgularının Yıllara Göre Değerlendirilmesi

KARA E., İNKAYA A. Ç., ÇALIK BAŞARAN N., ÖZYAVUZ ALP Ş., TÜMER A., ÜNAL S.

İnfeksiyon Dünyası Çalıştayı, Turkey, 24 - 27 March 2016, (Summary Text) Sustainable Development

55. Hacettepe Üniversitesi Tıp Fakültesi Hastanesi İnfeksiyon Hastalıkları Kliniğinde İzlenen HIV olgularının yıllara göre değerlendirilmesi

kara e., İNKAYA A. Ç., ÇALIK BAŞARAN N., ÖZYAVUZ ALP Ş., TÜMER A., ÜNAL S.

İNFEKSİYON DÜNYASI ÇALIŞTAYI, Ankara, Turkey, 24 - 27 March 2016, pp.118, (Summary Text)

56. What kind of agents can caıse MRONJ

EKMEKÇİOĞLU A., KÖSEOĞLU O. T., TÜZ H. H., SERHAT U., AKTAŞ A., ADİLOĞLU S., et al.

22nd International Conference on Oral and Maxillofacial Surgery, Melbourne, Australia, 27 - 30 October 2015, vol.44, pp.56, (Full Text)

57. Febril Nötropenik Hastada Granulicatella adiacens bakteriyemisi

Maçin S., İNKAYA A. Ç., TUNCER Ö., Özden Ö., AKYÖN YILMAZ Y., ÜNAL S.

3. ulusal klinik mikrobiyoloji kongresi-2015, Turkey, 18 - 22 November 2015

58. Nadir bir osteomiyelit çene absesi etkeni Granulicatella adiacens

TUNCER Ö., İNKAYA A. Ç., Maçin S., Özden Ö., AKYÖN YILMAZ Y., ÜNAL S.

3. ulusal klinik mikrobiyoloji kongresi-2015, Turkey, 18 - 22 November 2015

59. What kind of agents can use cause MRONJ medication related osteonecrosis of the jaw

EKMEKÇİOĞLU A., KÖSEOĞLU O. T., TÜZ H. H., ÜNAL S., AKTAŞ A., ADİLOĞLU S., et al.

22 nd Internatıonal Conference on Oral Maxillofacial Surgery, Melbourne, Australia, 27 - 30 October 2015, vol.44, pp.56, (Full Text)

60. What kind of agents can cause MRONJ (medication-related osteonecrosis of the jaw)?

Aylin E., KÖSEOĞLU O. T., TÜZ H. H., ÜNAL S., AKTAŞ A., ADİLOĞLU S., et al.

22nd International Conference on Oral Maxillofacial Surgery, Melbourne, Australia, 27 - 30 October 2015, vol.44, pp.56, (Summary Text)

61. What kind of agents can use cause MRONJ?

Ekmekcioğlu A., KÖSEOĞLU O. T., TÜZ H. H., ÜNAL S., AKTAŞ A., ADİLOĞLU S., et al.

22nd İnternational Conference on Oral and Maxillofacial Surgery,Melbourne,Australia, 27 - 30 October 2015, (Summary Text)

62. Serological Detection of Strongyloides strecoralis infection in immunosupressed patients Hacettepe Experience

Kaya F., ERTENLİ A. İ., İNKAYA A. Ç., ABBASOĞLU O., AKSOY S., AKYÖN YILMAZ Y., et al.

Acta Microbiologica Helenica (9th Balkan Congress of Microbiology), 22 - 24 October 2015

63. SEROLOGICAL DETECTION OF STRONGYLOIDES STERCORALIS INFECTION IN IMMUNOSUPRESSED PATIENTS: HACETTEPE EXPERIENCE

DEMİREL KAYA F., ERTENLİ A. İ., İNKAYA A. Ç., ABBASOĞLU O., AKSOY S., AKYÖN YILMAZ Y., et al.

9TH BALKAN CONGRESS OF MICROBIOLOGY, SELANİK, Greece, 22 - 24 October 2015, (Summary Text)

64. Can we plan an implant surgery on patients who have risk of MRONJ

KÖSEOĞLU O. T., TÜZ H. H., ÜNAL S., EKMEKÇİOĞLU A., ADİLOĞLU S., AKTAŞ A., et al.

TAOMS2015, Bodrum, Türkiye, 19 - 22 May 2015

65. Can we plan an implant surgery on patients who have risk of MRONJ Medication Related Osteonecrosis of the Jaw

KÖSEOĞLU O. T., TÜZ H. H., ÜNAL S., EKMEKÇİOĞLU A., ADİLOĞLU S., AKTAŞ A., et al.

Turkish Association of Oral and Maxillofacial Surgery,22nd Internatıonal Scientific Congress, Muğla, Turkey, 19 - 22 May 2015, vol.1, pp.28, (Summary Text)

66. Berger HIV ile İlgili Damgalanma Ölçeği Türkçe Formunun psikometrik özellikleri ve HIV pozitif bireylerde demgalanma ile depresyonun ilişkisi

YILDIZ İ., BAŞAR K., KARADAĞ ÇAMAN Ö., İNKAYA A. Ç.

19. TPD Yıllık toplantı ve Klinik Eğitim Sempozyumu, Aydın, Turkey, 6 - 09 May 2015, vol.26, pp.3 Sustainable Development

67. Neuroimaging Findings of a Case with Primary LeptomeningealMelanomatosis

GÖÇMEN R., ACAR N. P., İNKAYA A. Ç., TUNCER M. A.

XXth. Synposium Neuroradiologicum 2014, İstanbul, Turkey, 7 - 12 September 2014, (Summary Text)

68. AIDS’li Hasta Balgamından İzole Edilen ve MALDI-TOF MS ile Tanısı Konan Bordetella bronchiseptica Trakeobronşiti

MAÇİN S., AKDOĞAN KITTANA F. N., İNKAYA A. Ç., ÖZYAVUZ ALP Ş., ÜNAL S., AKYÖN YILMAZ Y.

8.Ulusal Moleküler ve Tanısal Mikrobiyoloji Kongresi, Ankara, Turkey, 4 - 07 June 2014, (Summary Text)

69. Renal transplant alıcılarında görülen CMV enfeksiyonlarının serolojik ve moleküler tanısı

ÇİÇEK M., BORAL B., ŞENER Y. Z., AMAN A., İNKAYA A. Ç., ERDEM Y., et al.

8. Ulusal Moleküler ve Tanısal Mikrobiyoloji Kongresi, Ankara, Turkey, 4 - 07 June 2014, (Summary Text)

70. Osteoradionecrosis of maxilla with candida infection seen in the bone.

KÖSEOĞLU O. T., ADİLOĞLU S., Kolbaş A. R., AVAĞ C., Ekmekçioğlu A., ÜNAL S., et al.

8 th International Congress.AÇBİD.Antalya, 21 - 25 May 2014, (Summary Text)

71. Can we plan an implant surgery on patients who have risk of MRON?

KÖSEOĞLU O. T., TÜZ H. H., ÜNAL S., Ekmekcioğlu A., ADİLOĞLU S., AKTAŞ A., et al.

22nd Intrnational Scientific Congress,Bodrum, 19 May 2015 - 22 May 2014, (Summary Text)

72. HIV enfeksiyonu nedeniyle izlenen bireylerde ruhsal bozukluk yaygınlığı

KAMIŞ G. Z., BAŞAR K., YILDIZ M. İ., ÖZYAVUZ ALP Ş., İNKAYA A. Ç.

18. TPD Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, Antalya, Turkey, 23 - 26 April 2014, vol.25, pp.47-48 Sustainable Development

73. Kan kültürlerinden izole edilen Candida türlerinin PNA FISH yöntemiyle hızlı tanımlanmasının konvansiyonel tanımlama yöntemleriyle uyum ve antifungal tedavinin yönlendirilmesine olası etki yönünden değerlendirilmesi

DOĞAN AYÇIK Ö., İNKAYA A. Ç., GÜLMEZ KIVANÇ D., UZUN Ö., AKOVA M., ARIKAN AKDAĞLI S.

Febril Nötropeni Klavuz Toplantısı, Ankara, Turkey, 29 - 30 March 2014, (Summary Text)

74. VIRAL HEPATITIS SEROLOGY IN HIV INFECTED TURKISH PATIENTS

İNKAYA A. Ç., ÇERÇİ P., HELVACI Ö., ÖZYAVUZ ALP Ş., TÜMER A., ÜNAL S.

14TH EUROPEAN AIDS CONFERENCE, BRÜKSEL, Belgium, 16 - 19 October 2013, (Summary Text) Sustainable Development

75. Quantiferon-TB Test Can Be Usefull For Decision Of Anti-Tuberculosis Prophylaxis During Anti-TNF Treatment: Result Of Real Life

KALYONCU U., KILIÇ L., İNKAYA A. Ç., KARADAĞ Ö., Bilgen S. A., AKDOĞAN A., et al.

77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, United States Of America, 25 - 30 October 2013, vol.65, (Summary Text) Sustainable Development

76. Comparisons of procedure specific surgicalsite infection rates of a Turkish university hospitalwith Turkish national surveillance data

Y G., ÇINAR B., ZENGİN H., AYTAÇ H., BAŞTUĞ Z., ÇETİNKAYA ŞARDAN Y., et al.

2nd International Conference on Prevention and Infection Control (ICPIC 2013), Cenevre, Switzerland, 25 - 28 June 2013, (Summary Text)

77. Infections after transrectal prostate biopsy

İNKAYA A. Ç., ALP Ş., Cinar B., ZENGİN H. Y., Aytac H., Gelebek Y., et al.

28th International Congress of Chemotherapy and Infection Incorporating / 14th Asia-Pacific Congress of Clinical Microbiology and Infection, Yokohama, Japan, 5 - 08 June 2013, vol.42, (Summary Text)

78. Measurement of Hamilton Depression and Ham,lton Anxiety scores of Hepatitis B positive inactive carriers and chronic hepatitis B patients in order to invest,gate factors affecting their psychiatric condition

AKTUĞ DEMİR N., Çelik M., Kölgelier S., SÜMER Ş., Aksoz S., DEMİR L. S., et al.

14th International Symposium on Viral Hepatitis and Liver Disease, 22 - 25 June 2012, (Summary Text) Sustainable Development

79. FAMILY PHYSICIANS: ARE THEY REALLY AWARE OF HEPATITIS B?

Demir N. A., Inkaya A. Ç., Demir L. S., Guler S., Sahin E., Kolgelier S., et al.

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Costa Rica, 4 - 08 November 2011, vol.54, (Summary Text) Sustainable Development

80. EVALUATION OF KNOWLEDGE OF PEOPLE LIVING CLOSE PROXIMITY TO PATIENTS WITH HEPATITIS B VIRUS INFECTION

Inkaya A. Ç., Demir N. A., Balci M., Demir L. S., Yumlu N., Ciftci H., et al.

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 29 October - 02 November 2010, vol.52, (Summary Text) Sustainable Development

Books 10

Metrics

Publication

246

Publication (WoS)

140

Publication (Scopus)

124

Citation (WoS)

743

H-Index (WoS)

Citation (Scopus)

977

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sobiad)

H-Index (Sobiad)

Citation (Sum Other)

Project

Open Access

UN Sustainable Development Goals

Publications & Works